Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anatol Kontush

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Pediatric Research|March 7, 2003
Neonatal blood plasma is less susceptible to oxidation than adult plasma owing to its higher content of bilirubin and lower content of oxidizable Fatty acidsMarcel Wiedemann, Anatol Kontush, Barbara Finckh, et al.
Nature Reviews. Drug Discovery|May 24, 2014
HDL-targeted therapies: progress, failures and futureBronwyn A Kingwell, M John Chapman, Anatol Kontush, et al.
Current Atherosclerosis Reports|October 19, 2006
Alterations in lipoprotein defense against oxidative stress in metabolic syndromeBoris Hansel, Anatol Kontush, Dominique Bonnefont-Rousselot, et al.
Metabolites|July 27, 2022
Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDLSvetlana Schekatolina, Viktoriia Lahovska, Aleksandr Bekshaev, et al.
Pharmacology & Therapeutics|November 8, 2015
Therapeutic applications of reconstituted HDL: When structure meets functionMaryam Darabi, Isabelle Guillas-Baudouin, Wilfried Le Goff, et al.
Plos One|November 29, 2012
High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activitySandrine Chantepie, Andrea E Bochem, M John Chapman, et al.
Endocrinology, Diabetes & Metabolism|July 3, 2026
Evaluation of High-Density Lipoprotein Capacity to Acquire Free Cholesterol From Triglyceride-Rich Lipoproteins During Reverse Remnant-Cholesterol Transport in Familial HypercholesterolemiaShiva Ganjali, Judy B de Haan, Wilfried Le Goff, et al.
Handbook of Experimental Pharmacology|December 20, 2014
Structure of HDL: particle subclasses and molecular componentsAnatol Kontush, Mats Lindahl, Marie Lhomme, et al.
Proteomics. Clinical Applications|September 12, 2015
Proteomic and lipidomic analyses of paraoxonase defined high density lipoprotein particles: Association of paraoxonase with the anti-coagulant, protein SXenia Moren, Marie Lhomme, Alexandre Bulla, et al.
Current Medical Research and Opinion|July 19, 2006
One third of the variability in HDL-cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia: The Paris La Pitié StudyBoris Hansel, Anatol Kontush, Philippe Giral, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Pediatric Research|March 7, 2003
Neonatal blood plasma is less susceptible to oxidation than adult plasma owing to its higher content of bilirubin and lower content of oxidizable Fatty acidsMarcel Wiedemann, Anatol Kontush, Barbara Finckh, et al.
Nature Reviews. Drug Discovery|May 24, 2014
HDL-targeted therapies: progress, failures and futureBronwyn A Kingwell, M John Chapman, Anatol Kontush, et al.
Current Atherosclerosis Reports|October 19, 2006
Alterations in lipoprotein defense against oxidative stress in metabolic syndromeBoris Hansel, Anatol Kontush, Dominique Bonnefont-Rousselot, et al.
Metabolites|July 27, 2022
Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDLSvetlana Schekatolina, Viktoriia Lahovska, Aleksandr Bekshaev, et al.
Pharmacology & Therapeutics|November 8, 2015
Therapeutic applications of reconstituted HDL: When structure meets functionMaryam Darabi, Isabelle Guillas-Baudouin, Wilfried Le Goff, et al.
Plos One|November 29, 2012
High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activitySandrine Chantepie, Andrea E Bochem, M John Chapman, et al.
Endocrinology, Diabetes & Metabolism|July 3, 2026
Evaluation of High-Density Lipoprotein Capacity to Acquire Free Cholesterol From Triglyceride-Rich Lipoproteins During Reverse Remnant-Cholesterol Transport in Familial HypercholesterolemiaShiva Ganjali, Judy B de Haan, Wilfried Le Goff, et al.
Handbook of Experimental Pharmacology|December 20, 2014
Structure of HDL: particle subclasses and molecular componentsAnatol Kontush, Mats Lindahl, Marie Lhomme, et al.
Proteomics. Clinical Applications|September 12, 2015
Proteomic and lipidomic analyses of paraoxonase defined high density lipoprotein particles: Association of paraoxonase with the anti-coagulant, protein SXenia Moren, Marie Lhomme, Alexandre Bulla, et al.
Current Medical Research and Opinion|July 19, 2006
One third of the variability in HDL-cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia: The Paris La Pitié StudyBoris Hansel, Anatol Kontush, Philippe Giral, et al.
Pageof 14